1. Home
  2. JFU vs CPHI Comparison

JFU vs CPHI Comparison

Compare JFU & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 9F Inc.

JFU

9F Inc.

N/A

Current Price

$2.25

Market Cap

29.9M

Sector

Finance

ML Signal

N/A

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

N/A

Current Price

$0.45

Market Cap

25.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JFU
CPHI
Founded
2006
N/A
Country
China
China
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.9M
25.3M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
JFU
CPHI
Price
$2.25
$0.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.9K
★ 75.4K
Earning Date
12-09-2022
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $4,144,268.00
Revenue This Year
$4,000.66
N/A
Revenue Next Year
$5.00
N/A
P/E Ratio
$1.43
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.95
$0.38
52 Week High
$9.48
$19.19

Technical Indicators

Market Signals
Indicator
JFU
CPHI
Relative Strength Index (RSI) 34.80 31.33
Support Level N/A $0.38
Resistance Level $2.97 $0.68
Average True Range (ATR) 0.29 0.06
MACD -0.04 -0.01
Stochastic Oscillator 11.63 16.34

Price Performance

Historical Comparison
JFU
CPHI

About JFU 9F Inc.

9F Inc is a digital technology and wealth management service provider aiming to empower institutional partners with financial technologies as well as attract investors with investment opportunities that come with the vast potential of China's new consumer economy and the appreciation of world-wide assets and access to quality products at a competitive price. The Company's operations are organized into segments, consisting of E-commerce services, technology Empowerment service, and Wealth Management services.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

Share on Social Networks: